Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro

Samantha C. Higgins, Helen L. Fillmore, Keyoumars Ashkan, Arthur M. Butt, Geoffrey J. Pilkington

Research output: Contribution to journalArticlepeer-review

86 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Dual targeting NG2 and GD3A using Mab-Zap immunotoxin results in reduced glioma cell viability in vitro'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Neuroscience

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science